Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals, Inc. financial statements
Retension Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 6.3M | EODHD |
| Cash and equivalents | USD 18.9M | EODHD |
Retension Pharmaceuticals, Inc. financials on 6ix · Retension Pharmaceuticals, Inc. on 6ix